Form 4: Integra LifeSciences Director Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Jeffrey A. Graves, a director at Integra LifeSciences, reported the acquisition and disposal of common stock on May 9, 2024.
Summary
- On May 9, 2024, Jeffrey A. Graves, a director of Integra LifeSciences Holdings Corp, reported changes in beneficial ownership of the company's common stock.
- Graves acquired 1,582 shares of common stock at $0.
- He also acquired 8,696 shares of common stock at $0.
- Following these transactions, Graves directly owns 12,494 shares.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing. The sentiment is neutral as it simply reports transactions.
Industry Context
Form 4 filings are standard practice for company insiders (directors, officers, and major shareholders) to report transactions in their company's stock, providing transparency to the market.
Stakeholder Impact
- The filing provides transparency to shareholders regarding insider transactions.
Key Dates
| Date | Description |
|---|---|
| 05/09/2024 | Date of the reported transactions (acquisition and disposal of common stock) |
| 05/13/2024 | Date of signature by Attorney-in-Fact |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.